is this even eligible as it is just a treatment method, not an actual drug.
Immunopulse is not just a treatment method as if this were the case there would be no clinical trial. The method is the patented OMS electroporation and the drug is the DNA IL-12 plasmid, which stimulates production of IL12 protein.
to answer your question, Immunopulse is registered on Orphan Drug status for Merkel Cell